Latest Insider Transactions at Incyte Corp (INCY)
This section provides a real-time view of insider transactions for Incyte Corp (INCY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INCYTE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INCYTE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,144
+17.05%
|
-
|
|
Jun 15
2022
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,144
+16.75%
|
-
|
|
Jun 15
2022
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
4,288
+0.04%
|
-
|
|
Apr 09
2022
|
Maria E Pasquale EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-0.97%
|
$41,360
$80.95 P/Share
|
|
Apr 08
2022
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
43,993
-12.66%
|
$3,651,419
$83.23 P/Share
|
|
Apr 08
2022
|
Barry P Flannelly EVP & General Manager US |
BUY
Exercise of conversion of derivative security
|
Direct |
41,864
+19.17%
|
$2,930,480
$70.45 P/Share
|
|
Mar 31
2022
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
326
+3.78%
|
$25,754
$79.42 P/Share
|
|
Mar 31
2022
|
Wendy L Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+1.38%
|
$19,671
$79.42 P/Share
|
|
Mar 31
2022
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+4.13%
|
$18,960
$79.42 P/Share
|
|
Mar 31
2022
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
280
+3.19%
|
$22,120
$79.42 P/Share
|
|
Mar 31
2022
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
880
+0.01%
|
-
|
|
Mar 10
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
218,563
+0.19%
|
$15,736,536
$72.39 P/Share
|
|
Mar 09
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
70,517
+0.19%
|
$5,006,707
$71.72 P/Share
|
|
Mar 08
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.27%
|
$7,000,000
$70.67 P/Share
|
|
Mar 08
2022
|
Baker Bros. Advisors LP |
BUY
Exercise of conversion of derivative security
|
Indirect |
40,000
+0.37%
|
$880,000
$22.05 P/Share
|
|
Feb 22
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
99,800
+0.27%
|
$6,786,400
$68.07 P/Share
|
|
Feb 18
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
133,032
+0.18%
|
$9,046,176
$68.4 P/Share
|
|
Feb 17
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
292,972
+0.44%
|
$19,629,124
$67.56 P/Share
|
|
Feb 14
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
502,852
+0.77%
|
$33,188,232
$66.03 P/Share
|
|
Feb 11
2022
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,177
-1.03%
|
$77,682
$66.76 P/Share
|
|
Feb 11
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
276,507
+0.43%
|
$18,249,462
$66.88 P/Share
|
|
Feb 10
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
819,015
+0.84%
|
$54,874,005
$67.1 P/Share
|
|
Jan 31
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Open market or private sale
|
Direct |
7,375
-19.62%
|
$545,750
$74.19 P/Share
|
|
Jan 24
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-0.21%
|
$5,850
$75.34 P/Share
|
|
Jan 24
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-0.14%
|
$5,850
$75.34 P/Share
|
|
Jan 19
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
6,959
+15.59%
|
-
|
|
Jan 19
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
6,959
+11.11%
|
-
|
|
Jan 18
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-0.33%
|
$15,150
$75.01 P/Share
|
|
Jan 18
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-0.21%
|
$15,150
$75.01 P/Share
|
|
Jan 07
2022
|
Paula J Swain EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
10,870
-13.06%
|
$793,510
$73.31 P/Share
|
|
Jan 07
2022
|
Paula J Swain EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
10,870
+11.55%
|
$793,510
$73.21 P/Share
|
|
Jan 04
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.44%
|
$9,656
$71.81 P/Share
|
|
Jan 04
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.28%
|
$9,656
$71.81 P/Share
|
|
Jan 04
2022
|
Paula J Swain EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
9,319
-11.41%
|
$680,287
$73.46 P/Share
|
|
Jan 04
2022
|
Paula J Swain EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
9,319
+10.24%
|
$680,287
$73.21 P/Share
|
|
Jan 03
2022
|
Paul Trower Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,214
-10.8%
|
$599,622
$73.31 P/Share
|
|
Jan 03
2022
|
Paul Trower Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,214
+9.42%
|
$599,622
$73.21 P/Share
|
|
Jan 01
2022
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+17.08%
|
-
|
|
Jan 01
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
3,615
+10.43%
|
-
|
|
Jan 01
2022
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+11.42%
|
-
|
|
Jan 01
2022
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+18.43%
|
-
|
|
Jan 01
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,615
+6.86%
|
-
|
|
Jan 01
2022
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,463
+21.26%
|
-
|
|
Jan 01
2022
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,463
+20.11%
|
-
|
|
Jan 01
2022
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,926
+17.77%
|
-
|
|
Jan 01
2022
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+10.71%
|
-
|
|
Dec 31
2021
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+4.13%
|
$25,039
$73.4 P/Share
|
|
Dec 31
2021
|
Wendy L Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
260
+1.46%
|
$18,980
$73.4 P/Share
|
|
Dec 31
2021
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
289
+3.39%
|
$21,097
$73.4 P/Share
|
|
Dec 31
2021
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+4.53%
|
$18,469
$73.4 P/Share
|